Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
4.400
-0.040 (-0.90%)
At close: Apr 28, 2026, 4:00 PM EDT
4.410
+0.010 (0.23%)
After-hours: Apr 28, 2026, 5:51 PM EDT
Larimar Therapeutics Employees
Larimar Therapeutics had 71 employees as of December 31, 2025. The number of employees increased by 6 or 9.23% compared to the previous year.
Employees
71
Change (1Y)
6
Growth (1Y)
9.23%
Revenue / Employee
n/a
Profits / Employee
-$2,333,423
Market Cap
457.08M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 71 | 6 | 9.23% |
| Dec 31, 2024 | 65 | 23 | 54.76% |
| Dec 31, 2023 | 42 | 16 | 61.54% |
| Dec 31, 2022 | 26 | -5 | -16.13% |
| Dec 31, 2021 | 31 | 3 | 10.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Ginkgo Bioworks Holdings | 485 |
| REGENXBIO | 371 |
| 4D Molecular Therapeutics | 196 |
| Entrada Therapeutics | 152 |
| Aura Biosciences | 113 |
| Prelude Therapeutics | 79 |
| Armata Pharmaceuticals | 60 |
LRMR News
- 5 weeks ago - Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Larimar Therapeutics Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 7 weeks ago - Larimar Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Larimar Therapeutics to Participate in Upcoming Investor Conferences in March - GlobeNewsWire
- 2 months ago - Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering - GlobeNewsWire
- 2 months ago - Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering - GlobeNewsWire
- 2 months ago - Laminar Therapeutics Stock Is Popping Today: What's Going On? - Benzinga
- 2 months ago - Larimar Therapeutics (LRMR) Surges On FDA Breakthrough Therapy Designation - Benzinga